Interleukin-18 in chronic pain: Focus on pathogenic mechanisms and potential therapeutic targets
Chronic pain has been proven to be an independent disease, other than an accompanying symptom of certain diseases. Interleukin-18 (IL-18), a pro-inflammatory cytokine with pleiotropic biological effects, participates in immune modulation, inflammatory response, tumor growth, as well as the process o...
Saved in:
Main Authors: | Jie Ju (Author), Zheng Li (Author), Xiaoqian Jia (Author), Xiaoling Peng (Author), Jihong Wang (Author), Feng Gao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is interleukin-18 associated with polycystic ovary syndrome?
by: Li Rong, et al.
Published: (2011) -
Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD
by: Paul F. Miller
Published: (2024) -
Interleukin-22: a potential therapeutic target in atherosclerosis
by: Jin-Wen Luo, et al.
Published: (2021) -
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017) -
Targeting Emerging Pathogenic Mechanisms by Natural Molecules as Potential Therapeutics for Neurodegenerative Diseases
by: Yan Dou, et al.
Published: (2022)